261 related articles for article (PubMed ID: 18665584)
1. Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.
Kumar S; Jaller D; Patel B; LaLonde JM; DuHadaway JB; Malachowski WP; Prendergast GC; Muller AJ
J Med Chem; 2008 Aug; 51(16):4968-77. PubMed ID: 18665584
[TBL] [Abstract][Full Text] [Related]
2. Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1.
Peng YH; Ueng SH; Tseng CT; Hung MS; Song JS; Wu JS; Liao FY; Fan YS; Wu MH; Hsiao WC; Hsueh CC; Lin SY; Cheng CY; Tu CH; Lee LC; Cheng MF; Shia KS; Shih C; Wu SY
J Med Chem; 2016 Jan; 59(1):282-93. PubMed ID: 26642377
[TBL] [Abstract][Full Text] [Related]
3. Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors.
Cheng MF; Hung MS; Song JS; Lin SY; Liao FY; Wu MH; Hsiao W; Hsieh CL; Wu JS; Chao YS; Shih C; Wu SY; Ueng SH
Bioorg Med Chem Lett; 2014 Aug; 24(15):3403-6. PubMed ID: 24939758
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Kumar S; Malachowski WP; DuHadaway JB; LaLonde JM; Carroll PJ; Jaller D; Metz R; Prendergast GC; Muller AJ
J Med Chem; 2008 Mar; 51(6):1706-18. PubMed ID: 18318466
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.
Huang Q; Zheng M; Yang S; Kuang C; Yu C; Yang Q
Eur J Med Chem; 2011 Nov; 46(11):5680-7. PubMed ID: 21925773
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors.
Serafini M; Torre E; Aprile S; Massarotti A; Fallarini S; Pirali T
Molecules; 2019 May; 24(10):. PubMed ID: 31096672
[TBL] [Abstract][Full Text] [Related]
7. Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.
Serra S; Moineaux L; Vancraeynest C; Masereel B; Wouters J; Pochet L; Frédérick R
Eur J Med Chem; 2014 Jul; 82():96-105. PubMed ID: 24878638
[TBL] [Abstract][Full Text] [Related]
8. Taking advantage of the interaction between the sulfoxide and heme cofactor to develop indoleamine 2, 3-dioxygenase 1 inhibitors.
Wang Y; Jia S; Chen Y; Liao X; Jie R; Jiang L; Wang T; Wen H; Gan W; Cui H
Bioorg Chem; 2024 Jul; 148():107426. PubMed ID: 38733750
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 4- and 5-arylthiazolinethiones as inhibitors of indoleamine 2,3-dioxygenase.
Balti M; Plas A; Meinguet C; Haufroid M; Thémans Q; Efrit ML; Wouters J; Lanners S
Bioorg Med Chem Lett; 2017 Aug; 27(15):3607-3610. PubMed ID: 28651980
[TBL] [Abstract][Full Text] [Related]
10. Rational design of indoleamine 2,3-dioxygenase inhibitors.
Röhrig UF; Awad L; Grosdidier A; Larrieu P; Stroobant V; Colau D; Cerundolo V; Simpson AJ; Vogel P; Van den Eynde BJ; Zoete V; Michielin O
J Med Chem; 2010 Feb; 53(3):1172-89. PubMed ID: 20055453
[TBL] [Abstract][Full Text] [Related]
11. A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies.
Griglio A; Torre E; Serafini M; Bianchi A; Schmid R; Coda Zabetta G; Massarotti A; Sorba G; Pirali T; Fallarini S
Bioorg Med Chem Lett; 2018 Feb; 28(4):651-657. PubMed ID: 29398544
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.
Gaspari P; Banerjee T; Malachowski WP; Muller AJ; Prendergast GC; DuHadaway J; Bennett S; Donovan AM
J Med Chem; 2006 Jan; 49(2):684-92. PubMed ID: 16420054
[TBL] [Abstract][Full Text] [Related]
13. Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: pharmacophore modeling and molecular docking studies.
John S; Thangapandian S; Sakkiah S; Lee KW
Eur J Med Chem; 2010 Sep; 45(9):4004-12. PubMed ID: 20580138
[TBL] [Abstract][Full Text] [Related]
14. Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Williams DK; Markwalder JA; Balog AJ; Chen B; Chen L; Donnell J; Haque L; Hart AC; Mandal SK; Nation A; Shan W; Vite GD; Covello K; Hunt JT; Jure-Kunkel MN; Seitz SP
Bioorg Med Chem Lett; 2018 Feb; 28(4):732-736. PubMed ID: 29398543
[TBL] [Abstract][Full Text] [Related]
15. Spiro-Oxindole Skeleton Compounds Are Efficient Inhibitors for Indoleamine 2,3-Dioxygenase 1: An Attractive Target for Tumor Immunotherapy.
Yan D; Xu J; Wang X; Zhang J; Zhao G; Lin Y; Tan X
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563059
[TBL] [Abstract][Full Text] [Related]
16. Benzofuranquinones as inhibitors of indoleamine 2,3-dioxygenase (IDO). Synthesis and biological evaluation.
Carvalho C; Siegel D; Inman M; Xiong R; Ross D; Moody CJ
Org Biomol Chem; 2014 May; 12(17):2663-74. PubMed ID: 24608884
[TBL] [Abstract][Full Text] [Related]
17. Comparison study of different indoleamine-2,3 dioxygenase inhibitors from the perspective of pharmacodynamic effects.
Jiang X; Li X; Zheng S; Du G; Ma J; Zhang L; Wang H; Tian J
Int J Immunopathol Pharmacol; 2020; 34():2058738420950584. PubMed ID: 32962460
[TBL] [Abstract][Full Text] [Related]
18. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents.
Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L
Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673
[TBL] [Abstract][Full Text] [Related]
19. Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors.
Ding Y; Tang F; Xue X; Luo J; Hussain M; Huang Y; Wang Z; Jiang H; Tu Z; Zhang J
Bioorg Chem; 2019 Aug; 89():102870. PubMed ID: 31103493
[TBL] [Abstract][Full Text] [Related]
20. Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
Röhrig UF; Majjigapu SR; Grosdidier A; Bron S; Stroobant V; Pilotte L; Colau D; Vogel P; Van den Eynde BJ; Zoete V; Michielin O
J Med Chem; 2012 Jun; 55(11):5270-90. PubMed ID: 22616902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
